DPP-4 inhibitor has been demonstrated to play a protective role in cardiovascular diseases, including hypertension [9], cardiomyopathy [10], atherosclerosis [11], and peripheral vascular disease [12] via both GLP-1 dependent and independent effects. Here, DPP4 is linked to cardiovascular disorder.